Home › Trial NCT01687400
Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
- Trial IDNCT01687400
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorWashington University School of Medicine
- Enrollment114
- Start date2013-02-12
- ConditionsLeukemia, Myeloid, Acute · Myelodysplastic Syndromes
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.